Novel Mutation p.A64D in the Serpina7 Gene as a Cause of Partial Thyroxine-binding Globulin Deficiency Associated with Increases Affinity in Transthyretin by a Known p.A109T Mutation in the TTR Gene^[#]

Abstract

Partial thyroxine-binding globulin deficiency (TBG-PD) is an endocrine defect with a prevalence of 1:4 000 in newborns. Due to the presence of a single TBG gene on the X chromosome, most familial TBG defects follow an X-linked inheritance pattern. Abnormal T4 binding to T4-binding prealbumin (TTR) is a rare cause of euthyroid hyperthyroxinemia, which is transmitted by autosomal dominant inheritance. The purpose of the present study was to identify and characterize new mutations in the Serpina7 and TTR genes in a complete family with typical TBG-PD. All patients underwent clinical and biochemical evaluation. Sequencing of DNA, population screening by (SSCP) analysis, and bioinformatics studies were performed. Molecular studies revealed a novel p.A64D mutation in the exon 1 of Serpina7 gene associated with the previously reported p.A109T mutation in the exon 4 of TTR gene. To our knowledge, this is the first report of a patient with a TBG-PD by a mutation in Serpina7 that was coincident with a mutation in TTR gene that increased affinity of TTR for T₄. This work contributes to elucidate the molecular basis of the defects of thyroid hormone transport in serum and the improvement of the diagnosis avoiding unnecessary therapy.

Key words

thyroxine-binding globulin - transthyretin - partial TBG deficiency - euthyroid hyper­thyroxinemia - serpina7 gene - TTR gene - mutation

^# In memory of Professor Hugo Niepomniszcze.

^* These authors contributed equally to this work.

• References

• 1 Hayashi Y, Mori Y, Janssen OE, Sunthornthepvarakul T, Weiss RE, Takeda K, Weinberg M, Seo H, Bell GI, Refetoff S. Human thyroxine-binding globulin gene: Complete sequence and transcriptional regulation. Mol Endocrinol 1993; 7: 1049-1060
• 2 Flink IL, Bailey TJ, Gustefson TA, Markham BE, Morkin E. Complete amino acid sequence of human thyroxine binding globulin (TBG) deduced from cloned DNA: close homology to the serine antiproteases. Proc Natl Acad Sci USA 1986; 83: 7708-7712
• 3 Refetoff S. Inherited thyroxine-binding globulin abnormalities in man. Endocr Rev 1989; 10: 275-293
• 4 Fingerhut A, Reutrakul S, Knuedeler SD, Moeller LC, Greenlee C, Refetoff S, Janssen OE. Partial deficiency of thyroxine-binding globulin-Allentown is due to a mutation in the signal peptide. J Clin Endocrinol Metab 2004; 89: 2477-2483
• 5 Reutrakul S, Dumitrescu A, Macchia P, Moll GWJ, Vierhapper H, Refetoff S. Complete thyroxine-binding globulin (TBG) deficiency in two families without mutations in coding or promoter regions of the TBG gene: in vitro demonstration of exon skipping. J Clin Endocrinol Metab 2002; 87: 1045-1051
• 6 Refetoff S, Murata Y. X-chromosome-linked inheritance of the variant thyroxine-binding globulin in serum of Australian Aborigines: Its physical, chemical and biological properties. J Clin Endocrinol Metab 1985; 60: 356-360
• 7 Takamatsu J, Refetoff S, Charbonneau M, Dussault JH. Two new inherited defects of the thyroxine-binding globulin (TBG) molecule presenting as partial TBG deficiency. J Clin Invest 1987; 79: 833-840
• 8 Mori Y, Seino S, Takeda K, Flink IL, Murata Y, Bell GI, Refetoff S. A mutation causing reduced biological activity and stability of thyroxine-binding globulin probably as a result of abnormal glycosylation of the molecule. Mol Endocrinol 1989; 3: 575-579
• 9 Sarne DH, Refetoff S, Nelson JC, Dussault J. A new inherited abnormality of thyroxine-binding globulin (TBG-San Diego) with decreased affinity for thyroxine and triiodothyronine. J Clin Endocrinol Metab 1989; 68: 114-119
• 10 Takeda K, Mori Y, Sobieszczyk S, Seo H, Dick M, Watson F, Flink IL, Seino S, Bell GI, Refetoff S. Sequence of the variant thyroxine-binding globulin of Australian Aborigines: Only one of two amino acid replacements is responsible for its altered properties. J Clin Invest 1989; 83: 1344-1348
• 11 Mori Y, Takeda K, Charbonneau M, Refetoff S. Replacement of Leu227 by Pro in thyroxine-binding globulin (TBG) is associated with complete TBG deficiency in three of eight families with this inherited defect. J Clin Endocrinol Metab 1990; 70: 804-809
• 12 Bertenshaw R, Takeda K, Refetoff S. Sequencing of the variant thyroxine-binding globulin (TBG)-Quebec reveals two nucleotide substitutions. Am J Hum Genet 1991; 48: 741-744
• 13 Li P, Janssen OE, Takeda K, Bertenshaw RH, Refetoff S. Complete thyroxine-binding globulin (TBG) deficiency caused by a single nucleotide deletion in the TBG gene. Metabolism 1991; 40: 1231-1234
• 14 Yamamori I, Mori Y, Seo H, Hirooka Y, Imamura S, Miura Y, Matsui N, Oiso Y. Nucleotide deletion resulting in frameshift as a possible cause of complete thyroxine-binding globulin deficiency in six Japanese families. J Clin Endocrinol Metab 1991; 73: 262-267
• 15 Bertenshaw R, Sarne D, Tornari J, Weinberg M, Refetoff S. Sequencing of the variant thyroxine-binding globulin (TBG)-San Diego reveals two nucleotide substitutions. Biochim Biophys Acta 1992; 1139: 307-310
• 16 Miura Y, Mori Y, Yamamori I, Tani Y, Murata Y, Yoshimoto M, Kinoshita E, Matsumoto T, Oiso Y, Seo H. Sequence of a variant thyroxine-binding globulin (TBG) in a family with partial TBG deficiency in Japanese (TBG-PDJ). Endocr J 1993; 40: 127-132
• 17 Yamamori I, Mori Y, Miura Y, Tani Y, Imamura S, Oiso Y, Seo H. Gene screening of 23 Japanese families with complete thyroxine-binding globulin deficiency: Identification of a nucleotide deletion at codon 352 as a common cause. Endocr J 1993; 40: 563-569
• 18 Takeda K, Iyota K, Mori Y, Tamura Y, Suehiro T, Kubo Y, Refetoff S, Hashimoto K. Gene screening in Japanese families with complete deficiency of thyroxine-binding globulin demonstrates that a nucleotide deletion at codon 352 may be a race specific mutation. Clin Endocrinol (Oxf) 1994; 40: 221-226
• 19 Janssen EO, Chen B, Büttner C, Refetoff S, Scriba PC. Molecular and structural characterization of the heat-resistant thyroxine-binding globulin-Chicago. J Biol Chem 1995; 270: 28234-28238
• 20 Ueta Y, Mitani Y, Yoshida A, Taniguchi S, Mori A, Hattori K, Hisatome I, Manabe I, Takeda K, Sato R, Ahmmed GU, Tsuboi M, Ohtahara A, Hiroe K, Tanaka Y, Shigemasa C. A novel mutation causing complete deficiency of thyroxine binding globulin. Clin Endocrinol (Oxf) 1997; 47: 1-5
• 21 Carvalho GA, Weiss RE, Vladutiu AO, Refetoff S. Complete deficiency of thyroxine-binding globulin (TBG-CD Buffalo) caused by a new nonsense mutation in the thyroxine-binding globulin gene. Thyroid 1998; 8: 161-165
• 22 Carvalho GA, Weiss RE, Refetoff S. Complete thyroxine-binding globulin (TBG) deficiency produced by a mutation in the acceptor splice site causing frameshift and early termination of translation (TBG-Kankakee). J Clin Endocrinol Metab 1998; 83: 3604-3608
• 23 Yorifuji T, Muroi J, Uematsu A, Momoi T, Furusho K. Identification of a novel variant of the thyroxine-binding globulin (TBG) in a Japanese patient with TBG deficiency (abstract). Horm Res 1998; 50 (Suppl. 03) 68
• 24 Janssen OE, Astner ST, Grasberger H, Gunn SK, Refetoff S. Identification of thyroxine-binding globulin-San Diego in a family from Houston and its characterization by in vitro expression using Xenopus oocytes. J Clin Endocrinol Metab 2000; 85: 368-372
• 25 Miura Y, Hershkovitz E, Inagaki A, Parvari R, Oiso Y, Phillip M. A novel mutation causing complete thyroxine-binding globulin deficiency (TBG-CD-Negev) among the Bedouins in southern Israel. J Clin Endocrinol Metab 2000; 85: 3687-3689
• 26 Reutrakul S, Janssen OE, Refetoff S. Three novel mutations causing complete T(4)-binding globulin deficiency. J Clin Endocrinol Metab 2001; 86: 5039-5044
• 27 Domingues R, Bugalho MJ, Garrão A, Boavida JM, Sobrinho L. Two novel variants in thyroxine-binding globulin (TBG) gene behind the diagnosis of TBG deficiency. Eur J Endocrinol 2002; 146: 485-490
• 28 Su CC, Wu YC, Chiu CY, Won JG, Jap TS. Two novel mutations in the gene encoding thyroxine-binding globulin (TBG) as a cause of complete TBG deficiency in Taiwan. Clin Endocrinol (Oxf) 2003; 58: 409-414
• 29 Mannavola D, Vannucchi G, Fugazzola L, Cirello V, Campi I, Radetti G, Persani L, Refetoff S, Beck-Peccoz P. TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature. J Mol Med (Berl) 2006; 84: 864-871
• 30 Moeller LC, Fingerhut A, Lahner H, Grasberger H, Weimer B, Happ J, Mann K, Janssen OE. C-Terminal Amino Acid Alteration rather than Late Termination Causes Complete Deficiency of Thyroxine-Binding Globulin CD-NeuIsenburg. J Clin Endocrinol Metab 2006; 91: 3215-3218
• 31 Lacka K, Nizankowska T, Ogrodowicz A, Lacki JK. A Novel Mutation (del1711 G) in the TBG Gene as a Cause of Complete TBG Deficiency. Thyroid 2007; 17: 1143-1146
• 32 Domingues R, Font P, Sobrinho L, Bugalho MJ. A novel variant in Serpina7 gene in a family with thyroxine-binding globulin deficiency. Endocrine 2009; 36: 83-86
• 33 Akbari MT, Fitch NJ, Farmer M, Docherty K, Sheppard MC, Ramsden DB. Thyroxine-binding prealbumin gene: a population study. Clin Endocrinol (Oxf) 1990; 33: 155-160
• 34 Rosen HN, Moses AC, Murrell JR, Liepnieks JJ, Benson MD. Thyroxine interactions with transthyretin: a comparison of 10 naturally occurring human transthyretin variants. J Clin Endocrinol Metab 1993; 77: 370-374
• 35 Moses C, Rosen HN, Moller DE, Tsuzaki S, Haddow JE, Lawlor J, Liepnieks JJ, Nichols WC, Benson MD. A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J Clin Invest 1990; 86: 2025-2033
• 36 Rosen HN, Murrell JR, Liepnieks JL, Benson MD, Cody V, Moses AC. Threonine for alanine substitution at position 109 of transthyretin differentially alters human transthyretin’s affinity for iodothyronines. Endocrinology 1994; 134: 27-34
• 37 Scrimshaw BJ, Fellowes AP, Palmer BN, Croxson MS, Stockigt JR, George PM. A novel variant of transthyretin (prealbumin), Thr119 to Met, associated with increased thyroxine binding. Thyroid 1992; 2: 21-26
• 38 George PM, Sheat JM, Palmer BN. Detection of protein binding abnormalities in euthyroid hyperthyroxinemia. Clin Chem 1988; 34: 1745-1748
• 39 Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18: 2714-2723
• 40 Klapper I, Hagstrom R, Fine R, Sharp K, Honig B. Focusing of electric fields in the active site of Cu-Zn superoxide dismutase: effects of ionic strength and amino-acid modification. Proteins 1986; 1: 47-49
• 41 Refetoff S, Murata Y, Vassart G, Chandramouli V, Marshall JS. Radioimmunoassays specific for the tertiary and primary structures of thyroxine-binding globulin (TBG): measurement of denatured TBG in serum. J Clin Endocrinol Metab 1984; 59: 269-277
• 42 Refetoff S, Murata Y, Mori Y, Janssen OE, Takeda K, Hayashi Y. Thyroxine-binding globulin: organization of the gene and variants. Horm Res 1996; 45: 128-138
• 43 Lansteger W, Stockigt JR, Docter R, Költringer P, Lorenz O, Eber OF. Familial dysalbuminaemic hyperthyroxinaemia and inherited partial TBG deficiency: first report. Clin Endocrinol 1994; 40: 751-758
• 44 Fitch NJS, Akbari MT, Ramsden DB. An inherited non-amyloidogenic transthyretin variant, [Ser⁶]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J Endocrinol 1991; 129: 309-313
• 45 Lalloz MRA, Byfield PGH, Goel KM, Loudon MM, Thomson JA, Himsworth RL. Hyperthyroxinemia due to the coexistence of two raised affinity thyroxine-binding proteins (albumin and prealbumin) in one family. J Clin Endocrinol Metab 1987; 64: 346-352